5 observations as to where we are today, and what might lie ahead for Blockchain in Pharmaceutical Market Access.

Like anyone who knew him in our field, I am tragically saddened by the passing of Jack Whelan last Thursday. The fact that this day would ev

Time for an update on our working group, ‘The Aurora Project’ and our global patient-centricity survey with 2,346 responses.

In September I met with over a dozen clinical leaders to discuss evolving roles of patients in clinical trials. Can we set a new paradigm?